These studies reveal a novel mechanism underlying the role of the KLF1/Wnt/β‐catenin signaling pathway in cardiomyocyte proliferation and cardiac regeneration in mice, providing a potential therapeutic target for patients with myocardial damage and heart failure. This evidence concerns the gene KLF1 and heart failure.